India 'privately' against patent-overriding drug permits
Indian government has "privately reassured" industry lobby group US-India Business Council that the country would not invoke 'compulsory licensing' for commercial purposes that could allow local drugmakers to make cheaper products by overriding patents of big global players.
Mar 09, 2016, 09:22 AM IST
More medicines to be cheaper as govt planning to extend essential drugs list
Making more drugs subject to price caps will draw the ire of global drugmakers like Pfizer Inc, GlaxoSmithKline Plc and Abbott Laboratories.
Jun 24, 2014, 11:12 AM IST